InMode (NASDAQ:INMD – Get Free Report) and SNDL (NASDAQ:SNDL – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Profitability
This table compares InMode and SNDL’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InMode | 23.27% | 13.47% | 11.95% |
| SNDL | -1.19% | -1.02% | -0.85% |
Risk and Volatility
InMode has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500. Comparatively, SNDL has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
Institutional and Insider Ownership
Valuation and Earnings
This table compares InMode and SNDL”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InMode | $370.49 million | 2.38 | $93.83 million | $1.36 | 11.29 |
| SNDL | $677.32 million | 0.49 | -$11.29 million | ($0.03) | -42.67 |
InMode has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations for InMode and SNDL, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InMode | 1 | 6 | 1 | 0 | 2.00 |
| SNDL | 1 | 1 | 1 | 0 | 2.00 |
InMode presently has a consensus target price of $16.00, indicating a potential upside of 4.17%. SNDL has a consensus target price of $5.00, indicating a potential upside of 290.62%. Given SNDL’s higher probable upside, analysts clearly believe SNDL is more favorable than InMode.
Summary
InMode beats SNDL on 10 of the 12 factors compared between the two stocks.
About InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
About SNDL
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
